TCOYD

Call Directions Website

TCOYD Guided by the belief that every person with diabetes has the right to live a long, healthy and happy life!

Guided by the belief that every person with diabetes has the right to live a healthy, happy, and productive life, Taking Control of Your Diabetes educates and motivates people with diabetes to take a more active role in their condition.

*We love sharing the latest and greatest in diabetes education, but we are not your doctors! All of the information on our website, in our videos, on our podcasts, on our social media platforms, and in any other current or future communication method is for the purposes of general education only. Always consult with your medical team for testing, diagnosis, treatment, and medical advice before making any changes to your healthcare. AND if you think you are having a medical emergency, call 911.*

Can a CGM make a difference if you’re living with type 2 diabetes, even if you don’t take insulin?CGMs were once thought...
10/14/2026

Can a CGM make a difference if you’re living with type 2 diabetes, even if you don’t take insulin?

CGMs were once thought of primarily as a tool for people living with type 1 diabetes, but that’s changing. Whether you’re newly diagnosed or have been living with type 2 diabetes for decades, a CGM can give you a clearer picture of what’s happening with your glucose throughout the day.

In this article, we break down seven ways CGMs can support people living with type 2 diabetes, including helping you understand how food, exercise, stress, illness, and medications affect your glucose. We also look at how CGMs can help you see if your medications are working, improve A1C and time in range, guide insulin dosing, and stay on track between healthcare visits.

And you don’t have to take insulin to benefit from a CGM! Research has shown improvements in A1C and time in range among people living with type 2 diabetes who use CGM, including those taking medications such as GLP-1s and SGLT2 inhibitors. While access continues to improve, education, insurance coverage, and affordability remain important hurdles.

At the end of the day, a CGM is about more than seeing a glucose number. It can help you learn how your body responds to everyday life and give you information that can help you make more informed decisions about your diabetes management.

💬 What’s the most helpful thing you’ve learned, or would want to learn, from wearing a CGM?

Check out the full article through here: https://bit.ly/4jdMKXR

This content was created with support from Dexcom.

10/13/2026

What did the clinical trials find when once-weekly basal insulin was compared with daily basal insulin?

For people living with type 2 diabetes, the results are encouraging. Participants taking once-weekly basal insulin had similar A1C lowering compared with those taking daily basal insulin, including people starting insulin for the first time and those switching from another basal insulin.

In this conversation, Dr. Steve Edelman and Dr. Athena Philis-Tsimikas break down the results for A1C, time in range, and hypoglycemia. Studies using CGM showed improved time in range with both daily and weekly basal insulin, with no increase in hypoglycemia with the weekly option.

💬 If you could get comparable glucose management with one basal injection a week instead of seven, would you be interested?

🎧 Watch the full episode through here: https://bit.ly/4yzvAsl
This content was produced with support from Lilly.

10/12/2026

What if a serious liver condition was developing without any obvious symptoms? 👀

MASH, or metabolic dysfunction-associated steatohepatitis, is a form of fatty liver disease that causes inflammation and scarring in the liver. The risk is higher for people living with type 2 diabetes, and most people with MASH don’t experience symptoms that would let them know something is wrong.

In this conversation, Dr. Steve Edelman takes us inside Madrigal’s MASH Across America event, where a traveling liver the size of a house helped bring BIG attention to this often silent condition. He explains why knowing your risk matters, how a simple FIB-4 score using your age and routine blood tests can help estimate liver scarring, and some of the steps you can take to support your liver health.

💬 Have you ever asked your healthcare team about your liver health or FIB-4 score?

📖 Learn more about MASH and fatty liver disease at TCOYD.org!

From Dr. E: My Cardiac Saga ContinuesSeveral weeks ago, I shared my experience receiving an abnormal result on a cardiac...
10/12/2026

From Dr. E:

My Cardiac Saga Continues

Several weeks ago, I shared my experience receiving an abnormal result on a cardiac biomarker. So many of you responded with heart felt comments that I am still holding on to. In response to that test, my cardiologist ordered a treadmill stress echo.

I performed well, going up to level 5 and reaching 17 METS, with anything over 10 considered excellent. The nurses running the test were impressed and I was thrilled that my heart was in great shape. I was on cloud nine until I received a call from my cardiologist. She said they saw some small EKG changes at my peak capacity that showed ischemia. With 56 years of type 1 diabetes and decades living with chronic kidney disease, we decided that I should get a cardiac catheterization.

This procedure was on August 21st and it showed “multivessel disease”. Several arteries had significant blockages, and one was completely blocked, although collateral vessels provided an alternate route for blood flow. My team recommended coronary artery bypass graft surgery, or CABG. That's happening today.

The operation will take approximately five hours. My surgeons will use blood vessels from elsewhere in my body to create new routes around the blockages. I will spend four to seven days in the hospital, followed by a recovery that will require patience— something I'm better at prescribing than practicing. I'll also have a heart pillow to hold against my chest when I cough or sneeze, which I have been told feels like being hit with a sledge hammer.

This diagnosis should not have shocked me but it did, especially because I always exercised and felt that my heart was in good shape. For the first time in my life, I understood what situational depression could feel like. I felt guilt and shame. How could Steve Edelman develop the very complications he has spent his career helping people avoid? I felt like an impostor. Diabetes has stopped me in my tracks unlike anything before. I often said to myself “is this a bad dream” and “is this really happening to me?”
I've had to remind myself of something I would tell any of my patients: having a complication does not mean you failed. Knowing that as a physician and accepting it as a patient are two different things.

It took me a while to write this. I'm sharing it as I prepare to head into the operating room because I want to be open and honest with the community that has given me so much over the years. Please accept my apologies for not being able to respond for a while, and please talk to your healthcare team about your LDL cholesterol goal and whether a coronary artery calcium score or other evaluation is appropriate for you.

Today is hard, but I'm also grateful for the care I'm receiving and for all of you.
See you on the other side.
-Steve

10/11/2026

How can one injection of basal insulin actually last an entire week?

You might wonder if you get a big burst of insulin at the beginning of the week and then less and less as the days go by. But once-weekly basal insulins are designed to provide a steady release of background insulin throughout the entire week.

In this conversation, Dr. Steve Edelman and Dr. Athena Philis-Tsimikas explain the technology behind these once-weekly basal insulins, how they maintain steady background coverage, and why reaching a steady state is an important part of understanding how weekly basal insulin works.

💬 What questions do you have about how once-weekly basal insulin works?

🎧 Watch the full episode through here: https://bit.ly/4yzvAsl
This content was produced with support from Lilly.

10/10/2026

Could replacing the insulin-producing cells lost in type 1 diabetes become part of its future treatment?

One of the biggest challenges with islet cell transplantation has been getting enough insulin-producing cells. Newer stem-cell technology is changing that by allowing scientists to produce a much larger supply of islet cells without relying solely on deceased organ donors.

In this conversation, Dr. Steve Edelman and Dr. Jeremy Pettus discuss why stem-cell-derived islets are generating so much excitement in type 1 diabetes research. Early results have shown that some people receiving these cells can become insulin independent with glucose levels approaching the normal range and a major reduction in hypoglycemia.

There are still important challenges to solve, including protecting the transplanted cells from the immune system and understanding how well they continue working over many years. But progress in creating a reliable source of insulin-producing cells represents an important step forward in the research toward therapies that could one day restore the body’s ability to make insulin.
💬 What questions do you have about islet cell transplantation and the research toward a cure for type 1 diabetes?

Check out the full video through here: https://bit.ly/4dcTNwb
This content was produced with support from Vertex

10/09/2026

How has basal insulin evolved throughout the years and what does that mean for your patients now?

Older options such as NPH have noticeable peaksn and typically require more frequent dosing. Those peaks can contribute to glucose variability and lows, including during the night.

In this conversation, Dr. Steve Edelman and Dr. Jeremy Pettus look at how basal insulin has evolved from NPH to longer-acting options, including degludec, and glargine U300. Newer basal insulins provide flatter and more stable insulin levels with less variability than older options.

For patients who feel hesitant about starting insulin, understanding how much these treatments have changed can be reassuring. Today, there are more options to personalize basal insulin therapy around an individual patient’s needs and glucose patterns.

💬 What questions or concerns do patients most often have when basal insulin is first introduced?

🎥 Watch the full discussion through here: https://bit.ly/4hlH5wp

10/08/2026

What if taking your basal insulin meant one injection a week instead of one every day? 👀

Once-weekly basal insulin is offering a new way to think about insulin therapy for people living with type 2 diabetes. Clinical trials have shown similar A1C lowering compared with daily basal insulin, with the potential to reduce seven basal injections a week to just one.

In this conversation, Dr. Steve Edelman and Dr. Athena Philis-Tsimikas discuss how once-weekly basal insulin works, how it is started and adjusted, and what the research has shown about A1C, time in range, and hypoglycemia. They also explain why the story is different for people living with type 1 diabetes, what happens if you miss a dose, and how weekly insulin could fit alongside GLP-1 medications in the future.

💬 Would taking your basal insulin once a week instead of every day make diabetes management easier for you?

🎧 Watch the full episode through here: https://bit.ly/4yzvAsl

This episode was supported by Lilly.

Lilly's once-weekly basal insulin is officially here, and people living with type 2 diabetes now have two FDA-approved o...
10/07/2026

Lilly's once-weekly basal insulin is officially here, and people living with type 2 diabetes now have two FDA-approved options!

Lilly’s Onswik was recently approved by the FDA, making it the second once-weekly basal insulin approved this year for adults living with type 2 diabetes, following Novo Nordisk’s Awiqli. Instead of taking basal insulin every day, these newer options are designed to provide background insulin coverage with just one injection per week.

Why is this an exciting step forward? Clinical trials of both Onswik and Awiqli found that the once-weekly insulins lowered A1c similarly to daily basal insulins. In type 2 diabetes studies, the risk of severe hypoglycemia was also about the same as with daily basal insulin.

For people who rely on basal insulin, going from a daily injection to a weekly injection could make a meaningful difference in the day-to-day routine of diabetes management. Fewer injections may help simplify treatment, reduce some of the mental load that comes with remembering a medication every day, and make it easier to fit insulin into everyday life. And importantly, this added convenience doesn’t mean giving up effective glucose management based on the clinical trial results.

💬 Would taking basal insulin once a week instead of once a day make diabetes management feel more manageable? We’d love to hear your thoughts in the comments below.

📖 Read the full article through through here: https://bit.ly/4jvOQCw

10/06/2026

If a patient’s glucose keeps dropping overnight, more basal insulin probably isn’t the answer. Let us explain!

Overbasalization simply means a patient is receiving more basal insulin than they need. One of the clearest clues can be found on the CGM: repeated overnight lows or glucose consistently drifting downward while the patient sleeps.

In this conversation, Dr. Steve Edelman and Dr. Jeremy Pettus explain that basal insulin has a specific job—to meet background insulin needs and help keep glucose relatively stable when someone isn’t eating. It shouldn’t be used to make up for glucose elevations caused by meals.

That’s why the overnight CGM curve can be so informative. A relatively flat glucose pattern can help indicate that the basal dose is doing its job, while consistent rises or falls can signal that treatment may need another look.

💬 What CGM patterns have been most helpful for identifying when a patient’s basal insulin needs adjusting?

🎥 Watch the full discussion through here: https://bit.ly/4hlH5wp

Address

San Diego, CA
92121

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Telephone

+18009982693

Website

Alerts

Be the first to know and let us send you an email when TCOYD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Sponsored

Share

Category